175357-61-6 Usage
Chemical compound
1-Benzyl-3-butylpiperazine is a chemical compound with a molecular formula C15H24N2.
Piperazine derivative
It is a derivative of the chemical compound piperazine, which contains a benzyl group and a butyl group attached to the piperazine ring.
Medicinal chemistry
This chemical is used in the field of medicinal chemistry as a potential drug candidate for various therapeutic applications.
Psychoactive drug
It has been studied for its potential use as a psychoactive drug and has been identified as a designer drug in some illicit products.
Neurodegenerative diseases
1-Benzyl-3-butylpiperazine has been investigated for its potential as a therapeutic agent for treating neurodegenerative diseases.
Cancer treatment
It has also been studied for its potential as a treatment for cancer.
Psychoactive side effects
It is important to note that this compound may have psychoactive side effects and its use as a drug should be carefully regulated and monitored.
Check Digit Verification of cas no
The CAS Registry Mumber 175357-61-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,3,5 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 175357-61:
(8*1)+(7*7)+(6*5)+(5*3)+(4*5)+(3*7)+(2*6)+(1*1)=156
156 % 10 = 6
So 175357-61-6 is a valid CAS Registry Number.
InChI:InChI=1/C15H24N2/c1-2-3-9-15-13-17(11-10-16-15)12-14-7-5-4-6-8-14/h4-8,15-16H,2-3,9-13H2,1H3
175357-61-6Relevant articles and documents
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 17-18, (2008/06/13)
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of
2-Substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase [1]
Williams,Ciccarone,MacTough,Bock,Conner,Davide,Hamilton,Koblan,Kohl,Kral,Mosser,Omer,Pompliano,Rands,Schaber,Shah,Wilson,Gibbs,Graham,et al.
, p. 1345 - 1348 (2007/10/03)
-
